AAAAAA

   
Results: 1-7 |
Results: 7
POSTMARKETING SURVEILLANCE OF THE SAFETY OF CYCLIC ETIDRONATE
Authors: VANSTAA TP LEUFKENS H ABENHAIM L COOPER C
Citation: Tp. Vanstaa et al., POSTMARKETING SURVEILLANCE OF THE SAFETY OF CYCLIC ETIDRONATE, Pharmacotherapy, 18(5), 1998, pp. 1121-1128
USE OF ORAL XANTHINES IN THE ELDERLY AND EXTENT OF SILENT RISKS - INFORMATION FROM A DRUG DISPENSING DATABASE
Authors: VANGANSE E VINCKEN W LEUFKENS H ERNST P
Citation: E. Vanganse et al., USE OF ORAL XANTHINES IN THE ELDERLY AND EXTENT OF SILENT RISKS - INFORMATION FROM A DRUG DISPENSING DATABASE, Pharmacoepidemiology and drug safety, 6(2), 1997, pp. 135-136
SCENARIO ANALYSIS OF THE FUTURE OF CLINICAL PHARMACY
Authors: LEUFKENS H HEKSTER Y HUDSON S
Citation: H. Leufkens et al., SCENARIO ANALYSIS OF THE FUTURE OF CLINICAL PHARMACY, Pharmacy world & science, 19(4), 1997, pp. 182-185
A PROSPECTIVE FOLLOW-UP-STUDY OF 5669 USERS OF LANSOPRAZOLE IN DAILY PRACTICE
Authors: LEUFKENS H CLAESSENS A HEERDINK E VANEIJK J LAMERS CBHW
Citation: H. Leufkens et al., A PROSPECTIVE FOLLOW-UP-STUDY OF 5669 USERS OF LANSOPRAZOLE IN DAILY PRACTICE, Alimentary pharmacology & therapeutics, 11(5), 1997, pp. 887-897
SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES
Authors: LEUFKENS H HAAIJERRUSKAMP F BAKKER A DUKES G
Citation: H. Leufkens et al., SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES, BMJ. British medical journal, 309(6962), 1994, pp. 1137-1140
SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES
Authors: LEUFKENS H HAAIJERRUSKAMP F BAKKER A DUKES G
Citation: H. Leufkens et al., SCENARIO ANALYSIS OF THE FUTURE OF MEDICINES, BMJ. British medical journal, 309(6962), 1994, pp. 1137-1140
A STUDY OF THE EFFECTS OF EXPOSURE MISCLASSIFICATION DUE TO THE TIME-WINDOW DESIGN IN PHARMACOEPIDEMIOLOGIC STUDIES
Authors: VANSTAA TP ABENHAIM L LEUFKENS H
Citation: Tp. Vanstaa et al., A STUDY OF THE EFFECTS OF EXPOSURE MISCLASSIFICATION DUE TO THE TIME-WINDOW DESIGN IN PHARMACOEPIDEMIOLOGIC STUDIES, Journal of clinical epidemiology, 47(2), 1994, pp. 183-189
Risultati: 1-7 |